Designing a Global Market Access Strategy Built for MFN
From Pharma Market Access Insights - from Petauri Evidence by Petauri Evidence
April 21, 2026 · 1h 0m · Season 9 · Episode 9
About this episode
The episode discusses the impact of Most Favored Nation pricing on global pharmaceutical strategies and market access.
Send us Fan Mail How will Most Favored Nation (MFN) pricing reshape global pharmaceutical strategy? What do emerging Centers for Medicare & Medicaid Service (CMS) models such as GENEROUS, GLOBE, and GUARD mean for launch planning, pricing corridors, and payer expectations worldwide? How should global market access teams prepare for a more transparent and tightly connected pricing environment? MFN reform is already influencing how companies plan, price, and launch medicines around the worl...
Topics covered
- Most Favored Nation pricing
- global pharmaceutical strategy
- market access
- pricing corridors
- payer expectations
- launch planning
Keywords
- MFN
- pharmaceutical strategy
- CMS models
- pricing
- market access
- launch planning
- payer expectations
Mentioned in this episode
Organizations: Centers for Medicare & Medicaid Service, MFN, GENEROS, GLOBE, GUARD
Explore listener stats, chart rankings, contacts and more on the Pharma Market Access Insights - from Petauri Evidence podcast page.